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Treatment adherence
Abstract
Angela has been spending a fair bit of time with Sam in recent months. She is a 29-year-old single mother
with one child. She studies part-time at the local university and has managed to maintain acceptable
grades. She has bipolar disorder that has been well managed with medication, in different combinations
at different pOints in her illness. However, over the last month she has intermittently missed doses and is
consequently becoming unwell. It is puzzling that she is missing doses because she is very attached to
her child and last time she stopped medication her daughter was placed in care. The following
information was obtained from her in order to undertake a functional analysis. Financially, Angela was
managing well on her supporting parent benefit and the maintenance paid by the father of her child.
However, her former partner was sent to jail 3 months ago and the maintenance money he was sending
her dried up. As a consequence, she started falling behind in some bills about 8 weeks ago. She has told
you that this worries her. On top of this, her daughter started experiencing stomach aches last week and
is cranky most of the time. Angela has said that she thinks that her daughter may be lactose intolerant
and believes that her local GP did not take her concerns about her daughter's distress seriously enough
when she took her to see him 10 days ago. Since becoming involved with Sam, Angela has struggled to
keep a routine for her and her daughter and she says she forgets her medication from time to time.
Sometimes Angela loses interest in sex and she thinks that her medication might reduce her libido.
Angela has never received much help from her family because they don't agree with her diagnosis. He
father says that she is just an attention getter and that she puts it on. He says that is why she cut herself
when she was a teenager. Her father states that if she just stopped 'boozing' she wouldn't be so down and
need the medication. Angela disagrees, stating that she has been drinking to help her sleep for years and
is drinking no more or less now. Nonetheless, Angela has tried to cut down on her alcohol use over the
last month and this has interfered with her sleep.
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Enhancing Adherence to Medications
Mitchell K. Byrne
'Keep a watch also on the faults of the patients, which often make them lie about the
taking of things prescribed’ – Hippocrates of Cos, circa 400BC
Chapter Overview
Medication is an essential tool in the clinician’s armamentarium yet it is estimated
that 50% of patients with a chronic health condition fail to adhere to prescribed
treatments. This chapter outlines what we mean by adherence and the implications of
nonadherence in chronic health conditions. Difficulties in measuring adherence are
discussed, followed by a brief review of theoretical models used to explain
nonadherence. The chapter concludes with a discussion of the major practical issues
that affect patient adherence and strategies for clinical intervention.
Defining Adherence
Adherence to treatment has been defined as ‘the extent to which patients follow the
instructions they are given for prescribed treatments’ (Haynes, et al., 2005, p 2).
Within this definition it is possible to recognise four types of adherence behaviour:
Adoption, Consistency, Amount, and Cessation (Martin, Bowen, Dunbar-Jacob, &
Peri, 2000). Adoption reflects the number of prescriptions filled for the patient.
Consistency relates to how reliably the patient takes their medication on a day-to-day
basis over a specified period of time and picks up on fluctuations in medication taking
behaviour. Amount refers to medication taken over a cumulative period. ‘Amount’ of
adherence can reflect great variations in behaviour in that the patient my accumulate a
near normal dose of medication, while varying widely (both over and under dose) on
a daily basis. Finally, cessation of medication or ‘dropout’ can reflect permanently or
temporarily stopping medication taking.
Adherence and nonadherence are not seen as polar phenomenon. Rather, adherence
exists on a continuum from completely adherent, through levels of partial adherence,
to not taking medication at all (Aslani & du Pasquier, 2002). In addition, both the
form and intentionality of nonadherence may vary. For example, exceeding
recommended doses or consuming medications in a single dose rather than spread
across the day may be seen as nonadherence. Further, patients may vary on the degree
of intentionality with respect to nonadherence, with some patients intending to take
their medication as prescribed but failing to do so (due, for example, to forgetting)
and others intending (consciously deciding) not to take their medication as prescribed
(Aslani & du Pasquier, 2002).
Nonadherence in Chronic Illness
Within conventional medicine, the use of pharmacotherapy remains an essential
feature of clinical practice. However, medications are only effective if they are
appropriately used by patients. High rates of nonadherence have been observed in

conditions as diverse as glaucoma (Kowing, Messer, Slagle & Wasik, 2010),
hypertension (Pladevall et al., 2010) and asthma (Park et al., 2010) and is as much a
problem for children and adolescents as it is for adults (Dean, Walters and Hall,
2010). Across chronic medical conditions, nonadherence to prescribed medicines
accounts for a significant proportion of treatment failure (Balkrishnan, 2005) and is
associated with increased emergency department visits and hospitalisations (Sokol et
al., 2005; Patel & Zed, 2002). Poor adherence is found in preventative medicine as
well as acute and chronic health care regimens (Dunbar-Jacob, 1993) and remains a
key predictor of relapse in major mental health disorders (Ascher-Svanum et al.,
2006). Generally, adherence rates for prescribed medicines average 50% (Cutler &
Everett, 2010; WHO, 2003) and may cost as much as US$300 billion annually
(Balkrishnan & Jayawant, 2007).
Difficulties with adherence are pronounced in older patients who are more likely to
experience chronic health problems, with between 70% and 80% of persons over the
age of 65 taking at least one prescription medicine (Kaufman, Kelly, Rosenberg,
Anderson & Mitchell, 2002). Older patients often have additional impediments to
their adherence, such as physical and cognitive changes, which necessitate
individually designed or tailored treatment programs (Ruppar, Conn & Russell, 2008).
The success of efforts to promote self management of chronic health conditions needs
to also consider to whom the patient attributes responsibility for their health care,
which may not always be ‘the self’ (Audulv, Asplund & Norbergh, 2010).
Measuring Adherence
The measurement of adherence, particularly in clinical, ecologically valid studies,
remains a major challenge in adherence research. It is generally agreed that there is no
recognised ‘best method’ for assessing adherence (Byerly et al., 2007). Estimates of
adherence by prescribing physicians have been found to be inaccurate (Roth & Caron,
1978) as have pill counts (Morisky, Green & Levine, 1989). Physiological measures
often reflect only recent medication taking behaviour (Urquhart, 1994). The most
advanced method of medication monitoring to date – the Medication Events
Monitoring System ([MEMS®], Apex Corporation, Fremont, CA) – involves an
electronic record of each occasion the top of a medicine container is opened.
However, this does not provide information about whether the medication is actually
taken (Svarstad, Chewning, Sleath & Claesson, 1999).
The measurement of adherence can be broadly ascribed to two categories of activity:
objective measures of medication-taking, such as pill counts and electronic
monitoring; and subjective measures of medication use, such as clinician ratings or
patient questionnaire (Sajatovic, Velligan, Weiden, Valenstein & Ogedegbe, 2010).
Adherence may also be predicted by patient attitudes and beliefs as they relate to
treatment (Byrne, Deane & Caputi, 2008) or from their level of insight into their need
for treatment (Byrne & Deane, in press). While there appears to be no superior
method to gain an exact measurement of medication adherence, self-report measures,
particularly questionnaires, are the most efficient and cost effective method of

assessing medication adherence (Thompson Kulkarni & Sergejew, 2000). Given that
one of the goals of adherence measurement is to identify opportunities for the
enhancement of adherence behaviour, self report measures which include attitude and
belief dimensions, such as the Beliefs about Medicines Questionnaire (BMQ – Horne,
Weinman, & Hankins, 1999), may be particularly useful (Sajatovic et al., 2010).
In addition to measures which identify current adherence behaviour, several recent
measures have emerged which seek to predict which patients are likely to experience
difficulties with adherence to treatment. For example, the ASK-20 Adherence Barrier
Survey (Hahn et al., 2008; Matza et al., 2008) has proven useful in identifying barriers
to adherence across a range of chronic health conditions, including asthma,
depression, diabetes and congestive heart failure. Similarly, McHorney (2009) has
developed the Adherence Estimator, a three-item screening instrument which enables
healthcare providers to identify the propensity to adhere to medication among patients
with chronic illness. Finally, Byrne and his colleagues have developed a behavioural
rating scale which can be used to predict inpatient engagement with medications
among psychiatric patients (Byrne, Deane, Willis, Hawkins & Quinn, 2009).
Ultimately, the choice of the measure of adherence should be based not only on its
psychometric properties, but also on its utility with respect to the researcher or
clinicians goals (Farmer, 1999). In general, it is best that measures of adherence
employ a continuous scale so that variations in levels of adherence can be assessed
(Balkrishnan & Jayawant, 2007). Given that self-report as a single measure of
adherence has unacceptably low sensitivity (Stewart, 1987), when using self report
measures it is preferable to combine them with other sources of data or related
domains such as clinician reports or patient attitudes (Svarstad et al., 1999). This
might include not only multiple patient based measures, but also the ratings of
clinicians, which have been shown to broadly concur with patient ratings (Kampman
Lehtinen, & Lassila, 2001).
Explaining Nonadherence
The causes of nonadherence are multifaceted, but most explanatory models of
adherence behaviour focus on the individual patient (Dunbar-Jacob, 1993). It has been
observed that there is no consequence of nonadherence that is severe enough to ensure
that all patients will adhere to treatment (Cramer & Rosenheck, 1998). Patient
behaviour sometimes defies logic and common sense, however Health Psychology
has provided a range of models of which can be used explain adherence behaviour.
Among these, three specific models, collectively referred to as ‘Social Cognition
Models’, seem pre-eminent: The Health Beliefs Model (HBM: Strecher, Champion, &
Rosenstock, 1997); the Theory of Planned Behaviour (Ajzen & Fishbein, 2005); and
the Self Regulation Model (SRM – Leventhal, Leventhal & Contrada, 1998).
Health Beliefs Model (HBM)

The HBM proposes that adherence is the result of an individual’s cost-benefit analysis
of adherence behaviour. Further, the HBM suggests that four beliefs contribute to a
person’s adherence behaviour: what benefits they see arising from adherence
(‘benefits’, such as reduced symptoms); what barriers they anticipate to adherence
(‘costs’, for example, side effects); perceived vulnerability to the illness
(‘susceptibility’, such as the extent to which they believe that they might relapse); and
perceived severity of the outcome (‘severity’, i.e. how bad they appraise an illness
incident would be). Higher adherence is expected when the person sees themselves as
more susceptible to illness, the more severe they appraise the consequences of the
illness, the greater the expected treatment benefits and the lower the assessed barriers
to adherence (relative to benefit). These beliefs are influenced by other variables such
as the individual’s personality, the opinion of others and their previous experiences.
Theory of Planned Behaviour (TpB)
The fundamental premise of the TpB is that an individual’s behaviour may be
predicted by their intentions. The intention to perform a behaviour is a function of the
person’s attitude toward the behaviour (expected value), his/her subjective norm in
relation to the behaviour, and the individual’s perceived ability to perform the
behaviour, termed ‘behavioural control’. While the TpB assumes that an individual’s
intention to behave in a given fashion is directly related to their beliefs about
engaging in the behaviour, there is no assumption that beliefs are accurate; they may
be biased or irrational. Once beliefs have been formed, behaviour specific attitudes
are developed in relation to the specific behaviour, appraisals of social norms about
the behaviour and perceptions regarding control or ability to perform the behaviour.
Intentions to engage in the behaviour are seen to follow on from these attitudes in a
consistent manner.
Self Regulation Model
According to the SRM, patients’ responses to illness are a function of their evaluation
of the illness based on their own knowledge and perceptions. Central to the process of
responding is the recognition that illness (the experience of being unwell) is different
to disease (a condition involving diagnosed pathology). Illness is a subjective
experience that may or may not be associated with physical pathology (disease).
When faced with a health threat (being told that one has an illness), the individual
must construct a personal representation of the illness. Illness representations consist
of the patient’s own ‘common sense’ beliefs about their illness. This ‘cognitive’ level
of illness representation is paralleled by the generation and processing of concomitant
emotional responses.
In seeking to understand nonadherence (and therefore intervene to enhance
adherence), Social Cognition Models have identified a range of variables that relate to
the individual. These variables, and the implications for intervention, are detailed in
Table 1.

Table 1: Variables Affecting Adherence Derived from Social Cognition Models*
Variable
Perceived Benefit

Implication
Psycho education, motivational strategies,
strategies to enhance ‘insight’ (eg. Cognitive
therapy)
Perceived Costs
Motivational strategies, problem solving skills
Perceived Vulnerability Strategies to enhance insight, psycho
education
Perceived Severity
Psycho education, motivational strategies
Beliefs & Attitudes
Psycho education, strategies to enhance
‘insight’ or challenge irrational beliefs (such
as cognitive therapy)
Normative appraisal of
Enhancement of alignment with proothers beliefs
adherence others (therapeutic alliance with
clinician), involvement of carers, destigmatising mental ill-health (normalising
strategies),
Behavioural control/self- Problem solving strategies, motivational
efficacy
strategies, behavioural strategies (such as
‘behavioural tailoring’)
Recognition and
Psycho education, strategies to enhance
Representation of illness ‘insight’, motivational strategies
* The interventions listed under “Implications” are described below.

Model
HBM

HBM
HBM
HBM
TpB

TpB

TpB

SRM

Causes of Nonadherence
Patient factors alone do not fully explain why an individual does or does not adhere to
treatment. Generally, four categories are used to capture the variables contributing to
treatment adherence. These include factors associated with the treatment (such as
complexity); factors associated with the clinician (such as skill); factors associated
with the patient (such as insight); and factors associated with the relationship between
clinician and therapist (McDonald, Garg & Haynes, 2002). These variables usually
overlap (Meichenbaum & Turk, 1987), but their influences will be reviewed
separately.
Treatment Factors
Treatment factors incorporate a broad range of variables from characteristics of the
treatment setting through to the clarity of the prescriber’s instructions (Meichenbaum
& Turk, 1987). More than 35 years ago, Kasl (1975) asserted that knowledge of the
treatment regime can, in and of itself, provide information about the likelihood of
adherence. For example, the more complex the medication regimen, the more likely it
is that the patient will not adhere. Polypharmacy has been cited as an issue in
adherence across chronic health conditions (DiMatteo, 2004). Simplifying medication
regimens has proven effective in enhancing adherence in a range of chronic health

disorders, such as glaucoma (Robin, Novack, Covert, Crocket & Marcic, 2007) and
AIDS (Battaglioli-DeNero, 2007). It has been suggested that increasing from as few
as one to two doses per day is enough to affect adherence (MacKean & Elkington,
1983).
There is also substantial research on the influence of side effects on adherence. Side
effects are generally considered an issue across chronic health conditions (e.g. heart
failure – Wu, Moser, Lennie & Burkhart, 2008; blood pressure – Elliott, 2008; and
cancer – Faiman, 2007) and have received considerable attention in the management
of severe mental illness (Hamer & Haddad, 2007). While it is generally accepted that
negative side effects can reduce patient adherence and should be managed by the
clinician (Weinmann, Janssen & Gaebel, 2005), clinicians often over estimate the
extent to which side effects influence individual adherence decisions. Side effects are
a relatively uncommon reason reported by patients for nonadherence (Cooper et al.,
2007) and are not a consistent predictor of adherence in research studies (Lacro et al.,
2002).
Other ‘treatment’ related issues that influence adherence include accessibility, which
refers to how easy it is to get the medications. Issues such as difficulty travelling to
the pharmacy or doctor and not having sufficient funds to purchase the medications
are examples of accessibility barriers to adherence. Finally, a commonly reported
finding in chronic illness is that when patients are asymptomatic, they waiver in their
adherence to treatment. This is often explained in terms of the difficulty relating
treatment to illness when no symptoms are apparent or where symptoms are not egodystonic. Cardiovascular disease is a good example of chronic illnesses where
symptoms may not be detected by patients and where nonadherence to medications is
a major challenge (Munger, Van Tassell & LaFleur, 2007).
Patient Factors
There is a substantial literature on patient related factors associated with adherence.
This is in part due to the tendency of health researchers to focus on patient-centred
reasons for nonadherence (Dunbar-Jacob, 1993), and because the models of health
related behaviour, such as those reviewed above, focus on aspects of the individual. A
consistent finding in the literature is an association between poor medication
adherence and co-morbid substance abuse (Janssen et al., 2006). This is particularly a
problem in severe mental health disorders, where up to 50% of patients diagnosed
with schizophrenia meet criteria for a co-morbid diagnosis of substance abuse
disorder (Hunt, Bergen & Bashir, 2002).
Another patient related factor associated with poor adherence has been lack of insight
into illness (McEvoy, 1998). Insight is a term associated with various meanings, both
medical and non-medical. However, most definitions relate to an individual’s
‘understanding’ of a given situation. While much of the research into insight has
focussed on mental health (Amador et al., 1994), lack of insight into the need to

maintain treatment in order to maintain health is not confined to patients with
psychotic illnesses. For example, Shaw (2005) observes that glaucoma patients often
need to be convinced that there is something wrong with them before they will adhere
to preventative treatments.
Poor insight has been associated with reduced help seeking behaviour, dangerousness
to self and others, reduced treatment adherence and a generally poorer prognosis
(Yen, Yeh, Chen, & Chung, 2002). Most frequently, it is the patient’s absence of an
understanding that there is a need for treatment that predicts nonadherence in chronic
illness (Buckley, Wirshing, Bhushan, Pierre, & Wirshing, 2007). Insight problems are
likely to influence attitudes to treatment and the interplay of attitude and insight is
important given the association between attitudes toward medication and medication
adherence.
Attitude to Medication
Attitude to health behaviours have been central in Social Cognition Models (see
above) and thus are salient patient factors in relation to adherence behaviour. Patients’
cognitions (beliefs and attitudes) can have a profound affect on treatment outcomes –
directly through placebo (expectation that a substance or treatment will help when in
fact it is inert) and nocebo (expectation that a substance or treatment will cause harm
when in fact it is inert) effects and indirectly through their influence on patient
behaviour (Horne, 2006). Clinicians should not assume that they share similar beliefs
about medications with their patients (Ramström, Afandi, Elofsson, & Petersson,
2006). Patients hold complex beliefs about medicines and their failure to take
medications may be the result of ‘misguided’ beliefs (Grunfeld, Hunter, Sikka &
Mittal, 2005).
Cognitive Skills
Cognitive skills refer to a range of memory and executive functions that allow
humans to undertake complex behaviours. This includes planning a sequence of tasks,
overcoming unanticipated obstacles and remembering to do things. Cognitive
functioning can be affected by dementia, intellectual disability, substance misuse or
the aspects of mental disorders, such as concentration and memory in depression or
schizophrenia, (Neufeld, 2007). Cognitive skills deficits enhance the likelihood of
nonadherence to treatment (Wallace, Dyer & Penrod, 2006) and such deficits have
been attributed to nonadherence in a range of samples and disorders (for example,
older adults – Mackin & Arean, 2007; chronic heart failure patients – Callegari et al.,
2002; and patients with HIV – Waldrop-Valverde et al., 2006).
Motivation
A frequently cited factor in health behaviour change is the importance of ‘patient
motivation’ (Rollnick, Mason, & Butler, 2000) with motivation being found to be
directly related to treatment adherence (Brondolo & Mas, 2001). Motivation has often
mistakenly been seen as a trait or characterlogical feature of a person. However, it is

generally accepted that motivation is more accurately construed as a state or
situational disposition, affected by interpersonal processes and amenable to change
(Miller & Rollnick, 2002). The improvement of motivation, through specific
motivational enhancement techniques such as Motivational Interviewing, has
contributed to enhanced treatment adherence in a range of studies (Bisonó, Manuel &
Forcehimes, 2006), supporting the contention that motivation is an influential factor
in treatment adherence.
Clinician Factors
While patient adherence to prescribed treatments may be influenced by clinician
interventions (Petrilla, Benner, Battleman, Tierce & Hazard, 2005), not all clinicians
actively try to enhance patient adherence using research driven methodologies
(Ramström et al., 2006; Weinmann et al., 2005; Faris & Schopflocher, 1999; Stern et
al., 1999). Given that medication remains an essential component of treatment of
chronic health disorders, it could be asserted that effective implementation of
‘adherence therapies’ would be a core activity of health clinicians. Why this is not so
may be due to a multitude of clinician-based factors, including the clinician’s own
competencies, attitudes and resources (Byrne, Deane & Coombs, 2005). For example,
positive, or at least non-stigmatising attitudes towards patients are essential for the
development of effective clinician-patient relationships (Buchanan, Rohr, Stevak, &
Sai, 2007). However, there is no guarantee that clinicians in training hold appropriate
attitudes toward patients, nor that they develop them as a consequence of their
training relationships (Buchanan et al., 2007). If the clinician’s attitudes to medication
are negative, it is likely that their ability to work effectively with patients to facilitate
medication adherence would be compromised.
Clinicians’ beliefs about their own adequacy have also been shown to influence
intended engagement in specific professional behaviours. For example, mental health
clinicians engagement in adherence interventions (Byrne et al, 2008), pharmacists
delivery of medication advice and support (Farris & Schopflocher, 1999), paediatric
providers (paediatricians and nurse-practitioners) screening of risky adolescent
behaviours (Ozer et al., 2004), and the response by health care providers to domestic
violence victims (Gadomski, Wolff, Trip, Lewis, & Short, 2001) are diverse examples
where efficacy beliefs either increased or decreased the given behaviour.
Brawley and Culos-Reed (2000) observe that self-efficacy beliefs are not traits of the
individual but are sets of beliefs about specific areas of functioning. Self-efficacy
does not relate to a quantum of skills but rather utility of possessed skills in a given
situation. Self-efficacy can be enhanced through mastery experiences, but in the
absence of adequate knowledge and skills training experiences, self-efficacy for a
given behaviour can be expected to be low, reducing the likelihood of the clinician
engaging in the desired behaviour. Thus, attention to the needs of the clinician may be
as important as the focus on the patient when seeking to improve engagement in
treatment.

Relationship Factors
Collaborative therapeutic relationships are essential in enhancing adherence
(Sajatovic et al., 2005) and there is broad acceptance that the nature of the therapeutic
relationship between the treating clinician and the patient has an important impact
upon the outcomes of treatment (Ackerman & Hilsenroth, 2003; Horvath & Bedi,
2002) and may even serve as a predictor of treatment outcome (Howgego,
Yellowlees, Owen, Meldrum, & Dark, 2003). The therapeutic relationship between
clinician and patient has been referred to as the ‘therapeutic alliance’. Both the
behaviour of the clinician in session (Binder & Strupp, 1997) and the clinician’s
attitudes and expectations influence the development and maintenance of the
therapeutic alliance (Brossart, Willson, Patton, Kivlighan, & Multon, 1998). This
perspective emphasises the importance of non-specific features of therapy (i.e. those
unrelated to technique) as well as the need to facilitate clinician behaviours that
promote the alliance and clinician attitudes that sustain it.
Skilled use of specific activities within the therapy session may enhance the
likelihood of developing a strong therapeutic alliance. For example, significant
correlations have been found between poor alliance and the clinician’s failure to
structure the session (such as through the use of an agenda), address patient resistance
(for example by using techniques derived from motivational interviewing), adopting
an inflexible stance (lacking a collaborative framework for intervention) and using
destructive interventions (based on coercion) (Eaton, Abeles & Gutfreund, 1993).
Clinicians’ attributes and behaviours that positively affect the alliance, include the
ability to convey to the patient an adequate level of competence (with demonstrable
self-confidence), to be responsive and empathic, and to be flexible (Ackerman &
Hilsenroth, 2003). Furthermore, clinicians’ behaviours such as exploration, reflection
and attending to the patient’s past experiences also supported the establishment of the
alliance. Overall, collaborative clinician activities are usually associated with the
deepening of the therapeutic alliance (Ackerman & Hilsenroth, 2003)
Strategies for the Enhancement of Adherence
The range of adherence interventions that have been reported in the literature fall
broadly into three classes or approaches: psycho educational approaches; behavioural
strategies; and cognitive-behavioural interventions.
Psycho-educational Approaches
There is good reason to believe that enhanced patient knowledge about medications
can play an important role in adherence, especially where the patient holds negative
beliefs about treatment (Fernandez, Evans, Griffiths & Mostacchi, 2006). Knowledge
can enhance insight, the patient’s appreciation of the relationship between symptoms
and illness, treatment and recovery and thus improve motivation to adhere to
treatment.

The most successful psycho educational interventions are those that target both
behavioural and attitudinal change. This has been demonstrated by the failure of
numerous studies to effect significant changes in adherence or clinical functioning
using psycho-education alone (for example Mundt, Clarke, Burroughs, BrennMan, &
Griest, 2001). One domain that has recognised the importance of behavioural and
attitudinal variables in the success of psycho educational strategies is that of ‘health
literacy’. Health literacy refers to the extent to which individuals have the capacity to
obtain, process, and understand health information and services such that they are able
to make appropriate health decisions (Rawson et al., 2009). Lower rates health
literacy are associated with generally poorer health status, lower use of preventative
and screening health services, increased hospitalisation, lower adherence to treatment
and reduced self-management of chronic illness (DeWalt, Berkman, Sheridan, Lohr &
Pignome, 2004). According to Jorm and colleagues (1997), mental health literacy
comprises six facets:
1.
2.
3.
4.
5.
6.

Recognition of disorder
Knowledge and beliefs about causes
Knowledge and beliefs about self help
Knowledge and beliefs about professional help
Attitudes that facilitate recognition and help-seeking, and
Knowledge of how to seek information

Clearly in this model, attitudinal variables play an important role in a psychoeducational model. Furthermore, both recognition of disorder and knowledge and
beliefs about causes seem associated with insight, for which perhaps additional
(cognitive behavioural) interventions may be necessary in order to maximise the
benefits of psycho-educational strategies.
Behavioural Interventions
Treatment complexity has long been identified as a source of patient nonadherence
(Haynes, 1976). It is well known that patients with problems in ‘executive function’,
principally due to deficits in the frontal structures, particularly the pre-frontal cortex,
experience difficulties with attention, memory, abstraction and planning (Falloon,
Barbieri, Boggian & Lamonaca, 2007). Executive function deficits may be apparent in
patients who are elderly, intellectually disabled, or who have chronic and severe
mental health problems (such as depression and psychotic disorders). Given that
different patients will have different levels of cognitive functioning (and therefore
capacity to tolerate complex treatment regimes), a range of behavioural strategies
have emerged to assist patients to overcome their ‘functional’ barriers to adherence.
Unlike psycho-educational interventions, behavioural interventions are often tailored
specifically to the needs of the individual patient, thus increasing treatment
specificity.

One of the core strategies in behavioural self-management is the use of problem
solving techniques (Chang & D’Zurilla, 1996). Problem solving training has proven
useful and effective for both the treatment and prevention of a wide variety of clinical
problems (Falloon et al., 2007). Problem solving interventions aim to change both the
individual’s ‘problem orientation’ as well as the individual’s skills at solving
problems. Problem orientation refers to the extent to which the individual perceives
everyday life problems as ‘solvable’ and how capable they feel at initiating problem
solving strategies (self-efficacy). A particular strength of a problem solving approach
is that it is amenable to the use of worksheets and templates, enabling the individual
to experience self-efficacy and empowerment in the implementation of problem
solving strategies.
Across chronic health conditions, problem solving strategies hold additional benefits
relevant to the enhancement of adherence, such as improving readiness to recognise
problems (motivation), the normalisation of the experience of “problems” in life and
the development of skills in attributing causes of problems accurately (Chang,
Downey, & Salata, 2004). The process of problem solving also enhances the
perception of problems as challenges as opposed to catastrophes or situations to avoid
and offers the patient an opportunity to improve self-efficacy.
Cognitive Behavioural Interventions
Many aspects of Cognitive Behavioural Therapies (CBT) have been incorporated into
adherence interventions. Cognitive therapy (Beck, 1964; Beck, 1995) is based on the
precept that all psychological disorders involve the generation of dysfunctional or
distorted thoughts and it is these thoughts which influence mood and behaviour.
Cognitive-behavioural interventions to improve adherence aim to get patients actively
involved in their treatment and seek to work with patients to investigate the range of
factors that might influence medication-taking behaviour (Gray, Wykes & Gournay,
2002). Given the apparent benefits of CBT, cognitive and behavioural approaches
have formed the basis of most contemporary adherence programs such as Compliance
Therapy (Kemp et al, 1996; 1998), Medication Management (Gray, Wykes, Edmonds,
Leese, & Gournay, 2004) and more recently, Medication Alliance (Byrne, Deane,
Lambert & Coombs, 2004; Byrne & Deane, in press).
Motivational Interviewing (MI – Miller & Rollnick, 2002), which has been
incorporated into most CBT based interventions, is a directive counselling style that is
patient-centred and collaborative. The core strategy in MI is to assist the patient to
understand their reasons for and against a change in behaviour and to make decisions
about change that are intrinsically motivated. It is patient-centred as the focus is the
concerns and perspectives of the patient, rather than the clinician. While the ‘therapy’
may be directive, the term ‘interviewing’ is used to capture the process of listening
and strategic questioning rather than ‘teaching’ the patient.

MI emphasises a partnership relationship between the clinician and the patient and
seeks to elicit behaviour change within the patient by assisting them to explore and
resolve ambivalence. Furthermore, MI stresses the importance of supporting the
patient to generate arguments for change rather than reliance upon the clinician to
generate such information. Essentially, MI draws upon the idea that if a person can
talk themselves out of change, they may also talk themselves into change.
The process of MI involves the identification of the patient’s goals and values and an
awareness in the patient of the discrepancies between current behaviour, (such as
nonadherence) and personally relevant goals. From this awareness, the patient, rather
than the clinician, generates reasons for behaviour change (Burke, Arkowitz, &
Menchola, 2003). Ultimately, the patient’s readiness for change is thought to stem
from two main factors: the importance of change from the patient’s perspective and
the patient’s confidence in their ability to engage in the change process. MI
emphasises that the clinician must assess both importance and confidence and target
intervention to improve both. Confidence relates directly to the patient’s self-efficacy
and is a good predictor of treatment outcome (Burke et al., 2003).
Summary and Conclusions
The enhancement of adherence to treatment should be a core activity for all health and
allied health professionals. There are many interventions which aim to enhance
patient adherence and which intervention to choose should be determined from the
individual adherence behaviours of the patient. Detailed assessment of the factors
which predict non-adherence, with recognition of the motivational contingencies
influencing the patient’s behaviours, is the best strategy to use in order to determine
how to support improved adherence. This can, however, be time consuming and there
are brief strategies that the clinician can use which will enhance adherence among a
significant proportion of patients outlined as ‘quick tips’ in the following:
Quick Tips
•
•
•
•

•

Provide education about the illness and how treatment can assist: encourage
the patient to ask questions;
Listen to the patient’s fears and beliefs about treatment and correct false
beliefs or irrational fears;
Check that the patient understands what has been said about the illness and
treatment by asking them to explain their understanding of the situation;
Make sure all your recommendations are simple, personalised and built into
the patient’s daily rituals. WRITE DOWN IN SIMPLIFIED TERMS WHAT
YOU WANT THE PATIENT TO DO, WHEN, WHERE AND HOW OFTEN –
IF POSSIBLE, SHOW THE PATIENT WHAT YOU WANT;
Keep the treatment as simple as possible;

•
•
•
•

Use as little jargon as possible & as much reflective listening to the patient as
you can: be a team;
Send reminders & follow up notes (including appointment reminders), for
example, text messages on mobile phones;
Communicate with other members of the health team what your treatment plan
is so that the patient receives a consistent message;
Reward any improvement in adherence, not just complete “compliance”
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